Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Items 201–300 of 797
Pant, V., Xiong, S., Jackson, J. G., Post, S. M., Abbas, H. A., Quintás-Cardama, A., Hamir, A. N., & Lozano, G. (2013) · Genes & Development · doi:10.1101/gad.227249.113 · Cited by 84
“that Mdm2 monoubiquitinates p53 and primes it for subsequent polyubiquitination and degradation in collaboration with other proteins (Grossman et al. 2003; Li et al. 2003).”
BackgroundRegulation of p53 family members by the ubiquitin-like SUMO system
Stehmeier, P., & Muller, S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.002 · Cited by 83
Santiago, A., Li, D., Zhao, L., Godsey, A. C., & Liao, D. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0771 · Cited by 98
“Thus, in agreement with previous findings, monoubiquitination seems to enable nuclear export of p53 (Li et al., 2003; Carter et al., 2007).”
ResultParthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
Gopal, Y. N. V., Chanchorn, E., & Dyke, M. W. V. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0661 · Cited by 90
“mal degradation and/or nuclear exclusion (3, 4).”
Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer
Ashikari, D., Takayama, K., Tanaka, T., Suzuki, Y., Obinata, D., Fujimura, T., Urano, T., Takahashi, S., & Inoue, S. (2017) · Oncogene · doi:10.1038/onc.2017.225 · Cited by 83
Zhang, H., Xu, J., Long, Y., Maimaitijiang, A., Su, Z., Li, W., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312928 · Cited by 111
“The DREAM complex binds to E2F or CHR promoters to suppress their transcription, thereby inducing cell cycle arrest [28,64].”
Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation
Salmena, L., & Pandolfi, P. P. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2145 · Cited by 92
The role of MDM2 and MDM4 in breast cancer development and prevention
Haupt, S., Vijayakumaran, R., Miranda, P. J., Burgess, A., Lim, E., & Haupt, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx007 · Cited by 85
“The majority of these emerging therapies for targeting MDM2 and MDM4 are small molecule inhibitors; however, the majority bind preferentially to MDM2 (Li et al., 2003).”
BackgroundHe, F., Fenner, B. J., Godwin, A. K., & Kwang, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.3884-3892.2006 · Cited by 90
“In addition to polyubiquitination, monoubiquitination is involved in in vivo modification of tumor suppressors, such as p53 (2, 6, 22 ).”
BackgroundDifferential Regulation of Rad18 through Rad6-dependent Mono- and Polyubiquitination
Miyase, S., Tateishi, S., Watanabe, K., Tomita, K., Suzuki, K., Inoue, H., & Yamaizumi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409219200 · Cited by 93
Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease
Kojić, S., Radojkovic, D. P., & Faulkner, G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.643857 · Cited by 85
Proteolysis: anytime, any place, anywhere?
Pines, J., & Lindon, C. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-731 · Cited by 92
Lee, H.-R., Toth, Z., Shin, Y. C., Lee, J.-S., Chang, H., Gu, W., Oh, T.-K., Kim, M. H., & Jung, J. U. (2009) · Journal of Virology · doi:10.1128/jvi.02353-08 · Cited by 78
Self-citationCai, X., & Liu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804608105 · Cited by 77
“MDM2 has been shown to mediate monoubiquitination of p53 in the nucleus, which promotes p53 nuclear export by unmasking the NES of p53 (20, 23, 28, 29).”
BackgroundWang, Y.-C., Lin, R.-K., Tan, Y. C., Chen, J.-T., Chen, C., & Wang, Y. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.139 · Cited by 80
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Okamoto, K., Taya, Y., & Nakagama, H. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.021 · Cited by 76
Ubiquitin and Ubiquitin-Like Modifications of the p53 Family
Watson, I. R., & Irwin, M. S. (2006) · Neoplasia · doi:10.1593/neo.06439 · Cited by 76
RFWD3–Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage
Fu, X., Yucer, N., Liu, S., Li, M., Yi, P., Mu, J.-J., Yang, T., Chu, J., Jung, S. Y., O’Malley, B. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912094107 · Cited by 82
“The ubiquitination reaction was carried out as described (21).”
BackgroundSelf-citationDynamics of p53: A Master Decider of Cell Fate
Luo, Q., Beaver, J. M., Liu, Y., & Zhang, Z. (2017) · Genes · doi:10.3390/genes8020066 · Cited by 83
“Later, multiple types of Mdm2-mediated p53 ubiquitinylation were identified [21,43].”
BackgroundCancer Stemness: p53 at the Wheel
Ghatak, D., Ghosh, D. D., & Roychoudhury, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604124 · Cited by 83
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3504 · Cited by 74
“Indeed, whereas low amounts of MDM2 stimulate (poly)-monoubiquitination and nuclear export of p53, high levels promote its polyubiquitination and degradation (123).”
p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
Marcel, V., & Hainaut, P. L. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8336-3 · Cited by 88
Ultraviolet Radiation Induces Phosphorylation and Ubiquitin-Mediated Degradation of ΔNP63α
Westfall, M. D., Joyner, A. S., Barbieri, C. E., Livingstone, M., & Pietenpol, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.5.1685 · Cited by 91
Essential Roles of E3 Ubiquitin Ligases in p53 Regulation
Sane, S., & Rezvani, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020442 · Cited by 74
“Binding the N-terminal of Mdm2 to p53 protein impedes the transcriptional activities of p53 [20].”
BackgroundInfluentialSpeidel, D., Helmbold, H., & Deppert, W. (2005) · Oncogene · doi:10.1038/sj.onc.1209126 · Cited by 89
“Moreover, the initially low Mdm2 levels in 100 J/m2 UV-irradiated cells might even enhance cytosolic accumulation of p53, as Li et al. (2003) proposed that low Mdm2 levels might preferentially lead to an export of p53 to the cytosol rather than promote its nuclear degradation.”
BackgroundVelez, J. M., Miriyala, S., Nithipongvanitch, R., Noel, T., Plabplueng, C. D., Oberley, T., Jungsuwadee, P., Van Remmen, H., Vore, M., & St. Clair, D. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018005 · Cited by 73
“p53 is regarded as the guardian of the genome with the capability of regulating many life and death processes, but whether it plays a role in regulating retrograde signaling is unexplored. The best known function of p53 is its action as a transcription factor. p53 can activate or suppress expression of its target gene…”
BackgroundDevelopment of inhibitors in the ubiquitination cascade
Zhang, W., & Sidhu, S. S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.003 · Cited by 86
Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis
Hurst-Kennedy, J., Chin, L., & Li, L. (2012) · Biochemistry Research International · doi:10.1155/2012/123706 · Cited by 71
“Disruption of UPS function has been implicated in cancer pathogenesis and progression [53] and many cancer-related cellular processes are controlled by ubiquitination, including cell division, growth factor signaling, DNA damage repair, and apoptosis [54–57].”
BackgroundInactivation of the tumor suppressor p53 by long noncoding RNA RMRP
Chen, Y., Hao, Q., Wang, S., Cao, M., Huang, Y., Weng, X., Wang, J., Zhang, Z., He, X., Lu, H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026813118 · Cited by 71
“MDM2 also insulates p53 from the transcription-related DNA elements by directly associating and concealing its transactivation domain (9) or prompting its cytosolic accumulation through monoubiquitination (10).”
BackgroundTRIM8 modulates p53 activity to dictate cell cycle arrest
Caratozzolo, M. F., Micale, L., Turturo, M. G., Cornacchia, S., Fusco, C., Marzano, F., Augello, B., D’Erchia, A. M., Guerrini, L., Pesole, G., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19008 · Cited by 76
“Indeed, MDM2 itself can differentially catalyze either p53 polyubiquitination targeting p53 to degradation or p53 monoubiquitination promoting p53 nuclear export.(4) Moreover, the atypical ubiquitin ligase E4F1 catalyzes p53 ubiquitination at Lys320, which recruits p53 to chromatin.”
BackgroundUbiquitination of p53 at Multiple Sites in the DNA-Binding Domain
Chan, W. M., Mak, M. C., Fung, T. K., Lau, A., Siu, W. Y., & Poon, R. Y. C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0097 · Cited by 72
“associated with polyubiquitination and high levels of MDM2 (10).”
BackgroundGotoh, T., Vila-Caballer, M., Liu, J., Schiffhauer, S., & Finkielstein, C. V. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0994 · Cited by 80
“In most normal cells, p53 is cytoplasmic; however, it is primarily located in the nucleus in rapidly growing normal cells, transformed cells, and various tumor cells, including those from breast and colon (Liang and Clarke, 2001).”
BackgroundEfficient Exciton Transport in Layers of Self-Assembled Porphyrin Derivatives
Huijser, A., Suijkerbuijk, B. M. J. M., Klein Gebbink, R. J. M., Savenije, T. J., & Siebbeles (2008) · Journal of the American Chemical Society · doi:10.1021/ja075162a · Cited by 71
SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination
Lee, M. H., Lee, S. W., Lee, E. J., Choi, S. J., Chung, S. S., Lee, J. I., Cho, J. M., Seol, J. H., Baek, S. H., Kim, K. I., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1512 · Cited by 71
“Mdm2 is an ubiquitin ligase that promotes p53 ubiquitination and degradatio”
BackgroundRegulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
Xie, F., Zhang, Z., Van Dam, H., Zhang, L., & Zhou, F. (2014) · Cells · doi:10.3390/cells3040981 · Cited by 70
“However, it has been reported that only higher levels of Mdm2 promote p53 poly-ubiquitination and nuclear degradation, whereas lower levels of Mdm2 in fact induce mono-ubiquitination and nuclear export of p53 [41].”
BackgroundExtensive Post-translational Modification of Active and Inactivated Forms of Endogenous p53
DeHart, C. J., Chahal, J. S., Flint, S. J., & Perlman, D. H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030254 · Cited by 70
Boesten, L. S. M., Zadelaar, S. M., De Clercq, S., Francoz, S., van Nieuwkoop, A., Biessen, E. A. L., Hofmann, F., Feil, S., Feil, R., Jochemsen, A. G., et al. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401973 · Cited by 70
Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2
Joo, H. M., Kim, J.-Y., Jeong, J. B., Seong, K. M., Nam, S. Y., Yang, K. H., Kim, C. S., Kim, H. S., Jeong, M., An, S., et al. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.12.001 · Cited by 71
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 70
Nucleocytoplasmic transport in apoptosis
Ferrando‐May, E. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401626 · Cited by 79
Protein monoubiquitylation: targets and diverse functions
Nakagawa, T., & Nakayama, K. (2015) · Genes to Cells · doi:10.1111/gtc.12250 · Cited by 89
“Given that p53 hyperactivation as well as p53 loss is detrimental to cells, the amount and activity of this protein are tightly regulated by transcriptional and post-transcriptional mechanisms including monoubiquitylation-induced nuclear exclusion (Li et al. 2003; Kruse & Gu 2009).”
BackgroundE3 Ligases Determine Ubiquitination Site and Conjugate Type by Enforcing Specificity on E2 Enzymes
David, Y., Ternette, N., Edelmann, M. J., Ziv, T., Gayer, B., Sertchook, R., Dadon, Y., Kessler, B. M., & Navon, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234559 · Cited by 69
Shih, A., Zhang, S., Cao, H., et al. (2004) · PubMed · Cited by 69
Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer
Chen, C., Seth, A. K., & Aplin, A. E. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0182 · Cited by 81
“Additionally, monoubiquitin modification for transcription factors, such as Smad4 (16) and p53 (17), can also serve as a signal for transcription activation or trafficking, respectively.”
BackgroundMDM2 Is Required for Suppression of Apoptosis by Activated Akt1 in Salivary Acinar Cells
Limesand, K. H., Schwertfeger, K. L., & Anderson, S. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01846-05 · Cited by 77
Dysregulation of ubiquitin ligases in cancer
Qi, J., & Ronai, Z. A. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.09.001 · Cited by 73
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69
“Depending on the levels of MDM2, MDM2 is able to dictate different fates for p53; low levels of MDM2 catalyze monoubiquitination of p53, causing its translocation to the cytoplasm, while high levels of MDM2 catalyze polyubiquitination of p53 and its subsequent degradation [164].”
Backgroundp53 negatively regulates the expression of FAT10, a gene upregulated in various cancers
Zhang, D. W., Jeang, K.-T., & Lee, C. G. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209220 · Cited by 70
“Dysregulation of MAD2 has also been implicated in tumorigenesis (Michel et al., 2001; Wang et al., 2002; Li et al., 2003).”
BackgroundYi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kanıskan, H. Ü., Jin, J. J., & Gu, W. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01180-7 · Cited by 77
Self-citationRFP-mediated ubiquitination of PTEN modulates its effect on AKT activation
Lee, J. T., Shan, J., Zhong, J., Li, M., Zhou, B., Zhou, A., Parsons, R. E., & Gu, W. J. (2013) · Cell Research · doi:10.1038/cr.2013.27 · Cited by 75
Self-citationRegulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 80
“It is proposed that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote polyubiquitination and nuclear degradation of p53 (90).”
BackgroundRegulation of nucleocytoplasmic trafficking of viral proteins: An integral role in pathogenesis?
Fulcher, A. J., & Jans, D. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.019 · Cited by 70
“The best understood mechanism of regulating nuclear transport is through phosphorylation near the NLS/NES modifying recognition by IMP/EXP [37, 38] , but modifications such as acetylation, ubiquitinylation and sumoylation have also been described [39] [40] [41] to regulate nucleocytoplasmic trafficking of cellular pro…”
BackgroundGambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells
Gu, H.-Y., Rao, S., Zhao, J., Wang, J., Mu, R., Rong, J., Tao, L., Qi, Q., You, Q., & Guo, Q. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0624-2 · Cited by 66
“As an apoptosis inducer, p53 caused cell growth arrest, apoptosis, and senescence in response to various types of stimuli (Li et al. 2003).”
Liu, G., & Xirodimas, D. P. (2010) · Oncogene · doi:10.1038/onc.2009.494 · Cited by 71
The Many Faces of MDM2 Binding Partners
Riley, M. F., & Lozano, G. (2012) · Genes & Cancer · doi:10.1177/1947601912455322 · Cited by 72
hSSB1 regulates both the stability and the transcriptional activity of p53
Xu, S., Wu, Y., Chen, Q., Cao, J., Hu, K., Tang, J., Sang, Y., Lai, F., Wang, L., Zhang, R., et al. (2012) · Cell Research · doi:10.1038/cr.2012.162 · Cited by 69
USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168
Yu, M., Liu, K., Mao, Z., Luo, J., Gu, W. J., & Zhao, W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624478 · Cited by 72
“Cell-based Ubiquitylation Assay—The ubiquitylation assay was performed as previously described (34) with some modification.”
MethodSelf-citationOvarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53
Piao, S., Pei, H. Z., Huang, B., & Baek, S. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.011 · Cited by 68
The nucleolus directly regulates p53 export and degradation
Boyd, M. T., Vlatković, N., & Rubbi, C. P. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105143 · Cited by 70
“Monoubiquitylation appears to promote p53 nuclear export not leading to degradation, the latter requiring polyubiquitylation (Geyer et al., 2000; Li et al., 2003; Brooks and Gu, 2006; Carter et al., 2007), and more recently, p53 monoubiquitylation has been strongly linked to mitochondrial translocation and transactiva…”
BackgroundCIN85, a Cbl‐interacting protein, is a component of AMAP1‐mediated breast cancer invasion machinery
Nam, J., Onodera, Y., Mazaki, Y., Miyoshi, H., Hashimoto, S., & Sabe, H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601534 · Cited by 71
“In the case of Mdm2, this E3 ligase has been shown to evoke either mono- or polyubiquitination on the same substrate, p53 tumor suppressor protein, presumably depending on the concentration of cellular Mdm2 (Li et al, 2003).”
BackgroundClick chemistry for targeted protein ubiquitylation and ubiquitin chain formation
Rösner, D., Schneider, T., Schneider, D., Scheffner, M., & Marx, A. (2015) · Nature Protocols · doi:10.1038/nprot.2015.106 · Cited by 71
Portman, N., Milioli, H. H., Alexandrou, S., Coulson, R., Yong, A., Fernandez, K. J., Chia, K. M., Halilovic, E., Segara, D., Parker, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01318-2 · Cited by 64
Kojima, K., Konopleva, M., Samudio, I. J., Ruvolo, V., & Andreeff, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2712 · Cited by 64
“Mdm2 is involved in the nuclear export of p53, for which Mdm2 ubiquitin ligase activity is required (45).”
BackgroundA role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
Becker, K., Marchenko, N., Palacios, G., & Moll, U. M. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5756 · Cited by 63
Cyclin-Dependent Kinase 5 Regulates PSD-95 Ubiquitination in Neurons
Bianchetta, M. J., Lam, T. T., Jones, S. N., & Morabito, M. A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2388-11.2011 · Cited by 63
“All mice were bred and analyzed in accordance with institutional guidelines and as approved by the Institutional Animal Care and Use Committee of the University of Massachusetts Medical School, Worcester, MA. Acute forebrain slices.”
BackgroundMethodLatonen, L. (2011) · BioEssays · doi:10.1002/bies.201100008 · Cited by 68
Rigacci, S., Bucciantini, M., Relini, A., Pesce, A., Gliozzi, A., Berti, A., & Stefani, M. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.122283 · Cited by 64
“The unstructured N-terminal domain (residues 1–93) harbors an acidic transactivation domain (residues 1–62), where the binding site for mdm2 (an E3 ubiquitin ligase (4)) is located, and a proline-rich domain (residues 63– 93).”
BackgroundSOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence
Mallette, F. A., Calabrese, V., Ilangumaran, S., & Ferbeyre, G. (2010) · Aging · doi:10.18632/aging.100163 · Cited by 69
“Post-translational modifications like ubiquitination and phosphorylation that have been shown to control the nuclear localization of p53 [65,66,67] and STAT [68] could also control the nucleo-cytoplasmic shuttling of SOCS1.”
HDM2 phosphorylation by MAPKAP kinase 2
Weber, H. O., Ludwig, R. L., Morrison, D. K., Kotlyarov, A., Gaestel, M., & Vousden, K. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208389 · Cited by 74
Mdm2 in growth signaling and cancer: Mini review
Levav-Cohen, Y., Haupt, S., & Haupt, Y. (2005) · Growth Factors · doi:10.1080/08977190500196218 · Cited by 60
“Low levels of Mdm2 activity induce mono-ubiquitination and nuclear export of p53, whereas high levels promote polyubiquitination and nuclear degradation of p53 (Li et al. 2003).”
BackgroundCSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination
Latini, P., Frontini, M., Caputo, M., Gregan, J., Cipak, L., Filippi, S., Kumar, V., Vélez-Cruz, R., Stefanini, M., & Proietti-De-Santis, L. (2011) · Cell Cycle · doi:10.4161/cc.10.21.17905 · Cited by 60
“This form is the only one detectable without inhibiting the proteasome, since the proteasome immediately degrades the poly-ubiquitinated forms of p53.(24) A different pattern of ubiquitination is obtained by inhibiting the proteasome with MG132 (Fig.”
BackgroundMaking sense of ubiquitin ligases that regulate p53
Jain, A. K., & Barton, M. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.7.13445 · Cited by 66
“Table 1 presents a summary of numerous E3-ligases that target p53 and underscores the major premise of this review: Why are there so many E3-ligases that negatively regulate p53? We will address this question in a teleological manner by assuming there is specificity among these negative regulators p53, while others su…”
BackgroundGutierrez-Mariscal, F. M., Pérez‐Martínez, P., Delgado‐Lista, J., Yubero‐Serrano, E. M., Camargo, A., Delgado‐Casado, N., Cruz‐Teno, C., González, M. S., Rodríguez-Cantalejo, F., Castano, J. P., et al. (2011) · AGE · doi:10.1007/s11357-011-9229-1 · Cited by 69
“However, when the damage is being repaired, the levels of Mdm2 rise so that p53 is polyubiquitinated and taken away quickly for degradation (Li et al. 2003).”
BackgroundInfluentialRedox modulation of p53: Mechanisms and functional significance
Kim, D., Kundu, J. K., & Surh, Y. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20709 · Cited by 62
Sarkari, F., Wang, X., Nguyen, T., & Frappier, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016598 · Cited by 59
“USP7 has also been widely studied as a regulator of the p53 tumor suppressor [26,27,28,29,30].”
BackgroundCrosstalk between autophagy and intracellular radiation response (Review)
Hu, L., Wang, H., Huang, L., Zhao, Y. L., & Wang, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3719 · Cited by 64
Matijasevic, Z., Steinman, H. A., Hoover, K., & Jones, S. N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01108-07 · Cited by 58
“Mdm2 forms a complex with p53 and functions as an E3 ligase to target p53 for ubiquitination and proteosomal degradation (16, 18, 25 ), thereby inhibiting p53’s transactivation of genes whose products are involved in the regulation of cell growth and apoptosis (47).”
BackgroundA portrayal of E3 ubiquitin ligases and deubiquitylases in cancer
Satija, Y. K., Bhardwaj, A., & Das, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28129 · Cited by 71
Stress-specific response of the p53-Mdm2 feedback loop
Hunziker, A., Jensen, M. H., & Krishna, S. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-94 · Cited by 65
“Mono-ubiquitination of p53 by Mdm2 inhibits its transcriptional activity, while poly-ubiquitination triggers its degradation [12].”
BackgroundWu, H., & Leng, R. P. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15882 · Cited by 58
Involvement of p53 in oroxylin A‐induced apoptosis in cancer cells
Mu, R., Qi, Q., Gu, H.-Y., Wang, J., Yang, Y., Rong, J., Liu, W., Lu, N., You, Q., & Guo, Q. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20570 · Cited by 62
ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1
Gilpin, K. M., Chang, L., & Monteiro, M. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv020 · Cited by 58
Ikeda, H., & Kerppola, T. K. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-05-0496 · Cited by 64
“Many nuclear proteins are translocated to the cytoplasm upon ubiquitination, often as a prelude to their degradation (Tomoda et al., 1999; Fukuchi et al., 2001; Li et al., 2003; Fang and Kerppola, 2004).”
BackgroundWang, W., Wei, J., Zhang, H., Zheng, X., Zhou, H., Luo, Y., Yang, J., Deng, Q., Huang, S., & Fu, Z. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03888-1 · Cited by 64
“Single or lysine-63-based polyubiquitination can lead to p53 nuclear export and cytoplasmic relocation, ultimately leading to stabilization of p53 [39, 40].”
BackgroundCellular strategies for making monoubiquitin signals
Ramanathan, H. N., & Ye, Y. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.620943 · Cited by 64
“In contrast, high levels of Mdm2 activity, which induces polyubiquitination and degradation of p53 in the nucleus (Li et al., 2003).”
BackgroundTargeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, T., & Dai, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180009 · Cited by 62
Negative Regulation of p53 by the Long Isoform of ErbB3 Binding Protein Ebp1 in Brain Tumors
Kim, C. K., Nguyen, T. L. X., Joo, K. M., Nam, D., Park, J., Lee, K., Cho, S. W., & Ahn, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1882 · Cited by 61
Chen, B. B., & Mallampalli, R. K. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01824-08 · Cited by 57
Kawaguchi, Y., Ito, A., Appella, E., & Yao, T.-P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505772200 · Cited by 57
Shih, A., Zhang, S., Cao, H., Boswell, S. A., Wu, Y., Tang, H., Lennartz, M. R., Davis, F. B., Davis, P. J., & Lin, H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1355.3.11 · Cited by 83
“Because MDM2 is involved in p53 turnover (23), it was of interest to determine whether resveratrol and/or EGF altered the complexing of MDM2 and p53 in DU145 cells.”
BackgroundRegulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2
García‐Cano, J., Sánchez‐Tena, S., Sala-Gaston, J., Figueras, A., Viñals, F., Bartrons, R., Ventura, F., & Rosa, J. L. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12592 · Cited by 60
“Molecular Oncology published by John Wiley & Sons Ltd. labeling it for nuclear-cytoplasmatic shuttle (monoubiquitylation) or for proteasome-dependent degradation (polyubiquitylation) (Li, 2003).”
BackgroundPTEN: a default gate-keeping tumor suppressor with a versatile tail
Wang, X., & Jiang, X. (2008) · Cell Research · doi:10.1038/cr.2008.83 · Cited by 66
p53 ubiquitination by Mdm2: A never ending tail?
Coutts, A. S., Adams, C., & Thangue, N. B. L. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.008 · Cited by 72
Peroxisomal matrix protein receptor ubiquitination and recycling
Thoms, S., & Erdmann, R. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.046 · Cited by 77
“Other examples are p53 and Rad18 that are either monoubiquitinated for export from the nucleus, or they are polyubiquitinated for proteasomal degradation [6,7].”
Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
Ozaki, T., Yu, M., Yin, D., Sun, D., Zhu, Y., Bu, Y., & Sang, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4217-9 · Cited by 64
“tates its proteasomal degradation [72].”
Tumor suppressor p53 cross-talks with TRIM family proteins
Liu, J., Zhang, C., Wang, X., Hu, W., & Feng, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.003 · Cited by 60
Tanaka, A., Muto, S., Konno, M., Itai, A., & Matsuda, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0741 · Cited by 62
Zheng, X., Ruas, J. L., Cao, R., Salomons, F. A., Cao, Y., Poellinger, L., & Pereira, T. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02236-05 · Cited by 56
Levav-Cohen, Y., Goldberg, Z., Zuckerman, V., Grossman, T., Haupt, S., & Haupt, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.152 · Cited by 63
No Splicing, No Dicing: Non-proteolytic Roles of the Ubiquitin-Proteasome System in Transcription
Kodadek, T. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.077883 · Cited by 63
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.